-
Latest News
- Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells & extracellular vesicles in ME/CFS
- Legitimizing ME/CFS: indications of change over a decade (US)
- Cochrane review of exercise therapy for CFS: appointment of advisory group lead
- Suicide is a concern for the chronic invisible illness community
- Potential benefits of a ketogenic diet to improve response & recovery from physical exertion in people with ME/CFS
Archives
Tag Archives: rituxan
B-Lymphocyte depletion in patients with ME/CFS: the final rituximab trial results
B-lymphocyte depletion in patients With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: a randomized, double-blind, placebo-controlled trial by Oystein Fluge, Ingrid G. Rekeland, Katarina Lien, Hanne Thurmer, Petter C. Borchgrevink, Christoph Schafer, Kari Sorland, Jorg Assmus, Irini Ktoridou-Valen, Ingrid Herder, Merethe E. … Continue reading
Posted in News
Tagged B-lymphocyte depletion, Dr Oystein Fluge, Dr Peter Rowe, Prof Olav Mella, rituxan, rituximab
Comments Off on B-Lymphocyte depletion in patients with ME/CFS: the final rituximab trial results
Video interview with parent Mary Dimmock about her son and rituximab
Episode 78 of Llewellyn King’s ME/CFS Alert videos interviews Mary Dimmock, whose son has ME and who is receiving RITUXAN (rituximab) treatment privately. (24 mins)
Posted in News
Tagged Llewellyn King, Mary Dimmock, ME/CFS Alert, rituxan, rituximab, video
Comments Off on Video interview with parent Mary Dimmock about her son and rituximab
